Arecor Therapeutics plc (LON:AREC – Get Free Report)’s share price hit a new 52-week low during mid-day trading on Friday . The stock traded as low as GBX 54.75 ($0.67) and last traded at GBX 57 ($0.70), with a volume of 62242 shares traded. The stock had previously closed at GBX 74 ($0.90).
Arecor Therapeutics Trading Down 23.0 %
The business has a 50 day moving average of GBX 73.29 and a 200-day moving average of GBX 81.27. The stock has a market cap of £21.52 million, a PE ratio of -203.57 and a beta of -0.18. The company has a current ratio of 1.37, a quick ratio of 6.24 and a debt-to-equity ratio of 5.51.
About Arecor Therapeutics
Arecor Therapeutics plc is a biopharmaceutical company transforming patient care by bringing innovative medicines to market. Through the enhancement of existing medicines using our Arestat™ technology, we are developing a broad portfolio of therapies as part of our proprietary pipeline and through partnerships with leading pharmaceutical and biotech companies.
See Also
- Five stocks we like better than Arecor Therapeutics
- What is a Dividend King?
- ServiceTitan Made Waves in Its IPO, But Is the Stock a Buy?
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Netflix: Is This the Perfect Time to Buy a Streaming Powerhouse?
- What is Short Interest? How to Use It
- Goldman Sachs Unveils 3 Massive Opportunities for 2025 Investors
Receive News & Ratings for Arecor Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arecor Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
